Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

Dale C. Hesdorffer, Torbjorn Tomson, Emma Benn, Josemir W. Sander, Lena Nilsson, Yvonne Langan, Thaddeus S. Walczak, Ettore Beghi, Martin J. Brodie, W. Allen Hauser

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Purpose: In an analysis of four case-control studies of sudden unexpected death in epilepsy (SUDEP), we found that yearly frequency of generalized tonic-clonic seizures (GTCS) and antiepileptic drug (AED) polytherapy were associated with an increased risk for SUDEP. The prior analysis, however, did not evaluate AEDs and GTCS frequency concurrently. Methods: We combined data from the three case-control studies with information on the frequency of GTCS and AED therapy, that is, carbamazepine, phenytoin, valproic acid, and other AED therapy. Number of AEDs was also considered. Lamotrigine and GTCS frequency were considered separately in two of the case-control studies. Logistic regression analysis was used to evaluate GTCS frequency, each of the AEDs, and number of AEDs. Adjusted analysis of the different AEDs accounted for study, age at death, gender, and GTCS frequency. Key Findings: In crude analysis, GTCS frequency, AED polytherapy, and number of AEDs were associated with an increased risk for SUDEP. Analysis of individual AEDs and of number of AEDs, adjusting for GTCS frequency, revealed no increased risk associated with AEDs as monotherapy, polytherapy, or total number. GTCS frequency remained strongly associated with an increased risk for SUDEP. Significance: Our findings-that none of the AEDs considered were associated with increased SUDEP risk as monotherapy or as polytherapy when GTCS frequency was taken into account-provide a consistent message that number of GTCS increases SUDEP risk and not AEDs. These results suggest that prevention of SUDEP must involve increased efforts to decrease GTCS frequency in order to avert the occurrence of this devastating epilepsy outcome.

Original languageEnglish
Pages (from-to)249-252
Number of pages4
JournalEpilepsia
Volume53
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Sudden Death
Anticonvulsants
Epilepsy
Seizures
Case-Control Studies
Combination Drug Therapy
Drug Therapy
Carbamazepine
Valproic Acid
Phenytoin
Logistic Models
Regression Analysis

Keywords

  • Antiepileptic drugs
  • Case-control study
  • Epilepsy
  • Generalized tonic-clonic seizures frequency
  • SUDEP

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Hesdorffer, D. C., Tomson, T., Benn, E., Sander, J. W., Nilsson, L., Langan, Y., ... Hauser, W. A. (2012). Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia, 53(2), 249-252. https://doi.org/10.1111/j.1528-1167.2011.03354.x

Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. / Hesdorffer, Dale C.; Tomson, Torbjorn; Benn, Emma; Sander, Josemir W.; Nilsson, Lena; Langan, Yvonne; Walczak, Thaddeus S.; Beghi, Ettore; Brodie, Martin J.; Hauser, W. Allen.

In: Epilepsia, Vol. 53, No. 2, 02.2012, p. 249-252.

Research output: Contribution to journalArticle

Hesdorffer, DC, Tomson, T, Benn, E, Sander, JW, Nilsson, L, Langan, Y, Walczak, TS, Beghi, E, Brodie, MJ & Hauser, WA 2012, 'Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis', Epilepsia, vol. 53, no. 2, pp. 249-252. https://doi.org/10.1111/j.1528-1167.2011.03354.x
Hesdorffer, Dale C. ; Tomson, Torbjorn ; Benn, Emma ; Sander, Josemir W. ; Nilsson, Lena ; Langan, Yvonne ; Walczak, Thaddeus S. ; Beghi, Ettore ; Brodie, Martin J. ; Hauser, W. Allen. / Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. In: Epilepsia. 2012 ; Vol. 53, No. 2. pp. 249-252.
@article{a211f41eadd645bc85d8f9c3f29d1b65,
title = "Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis",
abstract = "Purpose: In an analysis of four case-control studies of sudden unexpected death in epilepsy (SUDEP), we found that yearly frequency of generalized tonic-clonic seizures (GTCS) and antiepileptic drug (AED) polytherapy were associated with an increased risk for SUDEP. The prior analysis, however, did not evaluate AEDs and GTCS frequency concurrently. Methods: We combined data from the three case-control studies with information on the frequency of GTCS and AED therapy, that is, carbamazepine, phenytoin, valproic acid, and other AED therapy. Number of AEDs was also considered. Lamotrigine and GTCS frequency were considered separately in two of the case-control studies. Logistic regression analysis was used to evaluate GTCS frequency, each of the AEDs, and number of AEDs. Adjusted analysis of the different AEDs accounted for study, age at death, gender, and GTCS frequency. Key Findings: In crude analysis, GTCS frequency, AED polytherapy, and number of AEDs were associated with an increased risk for SUDEP. Analysis of individual AEDs and of number of AEDs, adjusting for GTCS frequency, revealed no increased risk associated with AEDs as monotherapy, polytherapy, or total number. GTCS frequency remained strongly associated with an increased risk for SUDEP. Significance: Our findings-that none of the AEDs considered were associated with increased SUDEP risk as monotherapy or as polytherapy when GTCS frequency was taken into account-provide a consistent message that number of GTCS increases SUDEP risk and not AEDs. These results suggest that prevention of SUDEP must involve increased efforts to decrease GTCS frequency in order to avert the occurrence of this devastating epilepsy outcome.",
keywords = "Antiepileptic drugs, Case-control study, Epilepsy, Generalized tonic-clonic seizures frequency, SUDEP",
author = "Hesdorffer, {Dale C.} and Torbjorn Tomson and Emma Benn and Sander, {Josemir W.} and Lena Nilsson and Yvonne Langan and Walczak, {Thaddeus S.} and Ettore Beghi and Brodie, {Martin J.} and Hauser, {W. Allen}",
year = "2012",
month = "2",
doi = "10.1111/j.1528-1167.2011.03354.x",
language = "English",
volume = "53",
pages = "249--252",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "2",

}

TY - JOUR

T1 - Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

AU - Hesdorffer, Dale C.

AU - Tomson, Torbjorn

AU - Benn, Emma

AU - Sander, Josemir W.

AU - Nilsson, Lena

AU - Langan, Yvonne

AU - Walczak, Thaddeus S.

AU - Beghi, Ettore

AU - Brodie, Martin J.

AU - Hauser, W. Allen

PY - 2012/2

Y1 - 2012/2

N2 - Purpose: In an analysis of four case-control studies of sudden unexpected death in epilepsy (SUDEP), we found that yearly frequency of generalized tonic-clonic seizures (GTCS) and antiepileptic drug (AED) polytherapy were associated with an increased risk for SUDEP. The prior analysis, however, did not evaluate AEDs and GTCS frequency concurrently. Methods: We combined data from the three case-control studies with information on the frequency of GTCS and AED therapy, that is, carbamazepine, phenytoin, valproic acid, and other AED therapy. Number of AEDs was also considered. Lamotrigine and GTCS frequency were considered separately in two of the case-control studies. Logistic regression analysis was used to evaluate GTCS frequency, each of the AEDs, and number of AEDs. Adjusted analysis of the different AEDs accounted for study, age at death, gender, and GTCS frequency. Key Findings: In crude analysis, GTCS frequency, AED polytherapy, and number of AEDs were associated with an increased risk for SUDEP. Analysis of individual AEDs and of number of AEDs, adjusting for GTCS frequency, revealed no increased risk associated with AEDs as monotherapy, polytherapy, or total number. GTCS frequency remained strongly associated with an increased risk for SUDEP. Significance: Our findings-that none of the AEDs considered were associated with increased SUDEP risk as monotherapy or as polytherapy when GTCS frequency was taken into account-provide a consistent message that number of GTCS increases SUDEP risk and not AEDs. These results suggest that prevention of SUDEP must involve increased efforts to decrease GTCS frequency in order to avert the occurrence of this devastating epilepsy outcome.

AB - Purpose: In an analysis of four case-control studies of sudden unexpected death in epilepsy (SUDEP), we found that yearly frequency of generalized tonic-clonic seizures (GTCS) and antiepileptic drug (AED) polytherapy were associated with an increased risk for SUDEP. The prior analysis, however, did not evaluate AEDs and GTCS frequency concurrently. Methods: We combined data from the three case-control studies with information on the frequency of GTCS and AED therapy, that is, carbamazepine, phenytoin, valproic acid, and other AED therapy. Number of AEDs was also considered. Lamotrigine and GTCS frequency were considered separately in two of the case-control studies. Logistic regression analysis was used to evaluate GTCS frequency, each of the AEDs, and number of AEDs. Adjusted analysis of the different AEDs accounted for study, age at death, gender, and GTCS frequency. Key Findings: In crude analysis, GTCS frequency, AED polytherapy, and number of AEDs were associated with an increased risk for SUDEP. Analysis of individual AEDs and of number of AEDs, adjusting for GTCS frequency, revealed no increased risk associated with AEDs as monotherapy, polytherapy, or total number. GTCS frequency remained strongly associated with an increased risk for SUDEP. Significance: Our findings-that none of the AEDs considered were associated with increased SUDEP risk as monotherapy or as polytherapy when GTCS frequency was taken into account-provide a consistent message that number of GTCS increases SUDEP risk and not AEDs. These results suggest that prevention of SUDEP must involve increased efforts to decrease GTCS frequency in order to avert the occurrence of this devastating epilepsy outcome.

KW - Antiepileptic drugs

KW - Case-control study

KW - Epilepsy

KW - Generalized tonic-clonic seizures frequency

KW - SUDEP

UR - http://www.scopus.com/inward/record.url?scp=84856337692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856337692&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2011.03354.x

DO - 10.1111/j.1528-1167.2011.03354.x

M3 - Article

C2 - 22191685

AN - SCOPUS:84856337692

VL - 53

SP - 249

EP - 252

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 2

ER -